S m u m m a m ry y Ta T lk of o the h Wo W r o ksho h p Accelerators for IBT Linz-MediConsult U e e L i L nz n Forschungszentrum Jülich
|
|
- Marianna Carson
- 6 years ago
- Views:
Transcription
1 Accelerators for IBT
2 general requirements for IBT accelerators high reliability fast morning start-up ease of operation low operation cost ease of maintenance low maintenance cost low follow-up costs
3 accelerator types cyclotron synchrotron isochronous synchrocyclotron slow-cycling rapid-cycling NC vs SC FFAG non-scaling scaling
4 cyclotrons: isochronous IBA-C230: FHBPTC, UFPTI, UPHS and 17 other locations Compact isochronous cyclotron 235 MeV proton energy 300 na beam current, quasi-continuous Typical efficiency : 55 % Approx. weight: 220 T Diameter: 4.3 m normal conducting Conventional magnet coil: T RF Frequency: 106 MHz Dee voltage: 55 to 150 kv peak Data: D. Bertrand
5 cyclotron: isochronous Varian 250: PSI, RPTC Particle Energy Outer diameter Height Weight Extracted current RF power Magnetic field H 250 MeV 3.1 m 1.6 m <90 t (max)800 na 115 kw 2.4 (<4) T Design: H. Blosser, MSU superconducting Data: H. Röcken
6 IBA C400: ARCHADE? cyclotron: isochronous Particle H-Ne Energy (MeV/u) 400 (H:250) Outer diameter (m) 6.3 Height (m) Weight (t) Extracted current (na) 8 RF power (kw) 2x100 Magnetic field 2.5 (4.5) T superconducting Data: D. Bertrand
7 IBA S2C2 cyclotrons: synchrocyclotron super conducting Compact: Ø 2.5 m, height 2 m, weight <50 t Reliable: NbTi cryogen free coil, Repeatable: Standard high quality laminated steel Operable: Operator-free system, remote diagnostics 20 na average beam current at 230 MeV for PBS; Extraction efficiency >50% at 230 MeV 1 khz beam pulse repetition rate for PBS Data: D. Bertrand Still River Monarch250 Design: T. Antaya, MIT Ø 1.7 m, weight 20 t, 9 T, Nb3Sn coil, >10 na at 250 MeV
8 220º gantry Summary Talk of the Workshop one room facility 180º gantry L: 27 m, H: 13 m (scheduled for 2014) Data: D. Bertrand L: 14 m, H: 14 m (scheduled for 2011)
9 synchrotron: slow cycling LLUMC H Fermi Labs HIMAC He-Ar Hitachi, Toshiba U Tsukuba H Hitachi PTC-H H Hitachi HIT H-O GSI Marburg, NRoCK, H, C Siemens Shanghai H, C Siemens GHMC C Mitsubishi CNAO H-C CERN
10 GHMC 66.0m 38.4m C MeV/u max 1.3 x 10 9 pps Synchrotron Extraction RF Cavity 1/3 size and price of HIMAC ECR C 4+ RFQ APF-IH C 4+ Foil C 6+ 4 MeV/u Injector Data: T. Kanai
11 Ion type Energy Maximum range SOBP Maximum aperture Lateral field shaping Beam intensity Summary Talk of the Workshop Dose rate Beam delivery modes slow cycling synchrotron: GHMC Carbon only MeV/u 25 cm 2 14 cm (with ridge filters) 15 cm x 15 cm Single radius wobbling Spiral wobbling 1.3 x 10 9 pps (3 sec nozzle 5 GyE/min for φ15 cm 10 cm SOBP Respiration gating Layer Stacking Established extraction method yielding high stability in time, position, and size Data: T. Kanai
12 Data: P. Urschütz
13 Shanghai Cancer Center: Synchrotron w 4 treatment rooms (Siemens) Data: Zh. Zhang
14 Siemens Synchrotron produces proton MeV and carbon MeV/u slow extraction of beam over 1-10 s Shift from carbon to proton: in <1 min. Data: Zh. Zhang
15 Siemens Synchrotron produces proton MeV and carbon MeV/u slow extraction of beam over 1-10 s Shift from carbon to proton: in <1 min. COSY Jülich
16 Data: P. Urschütz
17 4 May 2011 Data: Zh. Zhang
18 Welcome to Shanghai Wish Erice Meeting Success!!! Forschungszentrum Zh. Zhang Jülich
19 synchrotron: rapid cycling Pros Compact construction (1-turn injection) good intensity control variable energy operation proven technology for physics applications (KEK, ISIS, J-PARC, RAL) Not yet realized for IBT Cons rapid frequency sweeps high RF voltage (16 kv for H and 100 kv for C) Eddy currents too costly? RCMS by BNL
20 synchrotrons: rapid-cycling Data: S. Peggs
21 FFAG Accelerator Magnetic Fixed Modulated Type Field Variation Frequency Frequency FFAG alternating + IsoC alternating + SynchroC uniform + * First prototype realized in 2000 (KEK)
22 FFAG: scaling vs non-scaling Scaling: B field follows a scaling law as a function of radius - rk (k a constant;) present-day scaling FFAGs: Y. Mori, Kyoto University Research Reactor Institute geometrically similar orbits Nonscaling: Linear (quadrupole) gradient; beam parameters generally vary significantly with energy (EMMA FFAG, Daresbury Laboratory, first nonscaling FFAG) Nonlinear-gradient; beam parameters such as machine tune can be fixed (as in a synchrotron, PAMELA and a new generation of constant-tune, CW FFAGs) compressed orbits Data: C. Johnstone
23 FFAG: Bringing the Community a Step Forward? Advantages of the FFAG : Simplicity of fixed magnetic fields rather than pulsed operation 12 C 6+ Potential for variable energy extraction Strong focusing allows synchrotron-like straights p 3.5 m Goal: lower operational overhead and system simplicity of the cyclotron Data: C. Johnstone
24 FFAG: PAMELA Particle Accelerator for MEdicaL Application Particle physics EMMA ν-factory, muon source, proton driver Medical PAMELA Particle therapy, BNCT, X-ray source Energy (PAMELA) ADSR, Nucl. Transmutation Particle therapy FFAG FFAG ADSR ν-factory CONFORM (Construction of a Non-scaling FFAG for Oncology, Research and Medicine) aims to develop the Non-scaling FFAG as a versatile accelerator. (Project HP: Data: T. Yokoi/J. Pozimski
25 polygonal Summary Talk of the Workshop RACCAM - new layout rectangular This results in : - Smaller overall surface : 3400 m 2 versus 4200 m 2 - A reduction of non-productive surface (e.g., beam transport) - Cost of building reduced : 16 M versus 18 M - Reduced walking distances and flux, both for personnel and patients - Reduced operationnal costs Note: An X-ray radiotherapy center for Toulouse has been proposed by AGC in a bid in 2009, based on this cylindrical layout Data: F. Méot
26 agony of choice Which medical accelerator to choose?
27 agony of choice Which medical accelerator to choose? For MDs the IBT part upstream of the patient is a black box
28 accelerator vs facility costs total facility costs cost of equipment cost of accelerator Varian MEuro MEuro 7-10 MEuro Data: IBA For a multiroom PT facility, the accelerator is NOT the size- and cost-determining factor!
29 Which accelerator to choose? Why do most PT centers use cyclotrons? Why do most IBT centers use synchrotrons? Why do industrial suppliers take the challenge of SC? Antagonism between preference of clients for proven technology and desire of developers for innovation
30 which accelerator to choose? Simplicity, reliability, lower cost and size IBA: i cyclotron, nc Smallest possible footprint and weight, less power consumption Varian: i cyclotron, sc Simple, robust, low voltage, low cost, compact,... T. Antaya, synchrocyclotron, sc Simple, robust, small magnets, light gantry, flexible S. Peggs, RCMS Smaller, simpler, significantly cheaper than synchrotron CONFORM Project: FFAG
31 the benchmark for a new IBT system yr LC 100% 5-yr LC 33.9% 70.4 GyE/16 f./4 wks (0006, n=25) LogRank p< or 57.6 GyE (9602, n=16).2 Sarcomas of the H & N TIME 観察期間 IN ( 月 MONTH ) Data: H. Tsujii
32 clinical operation with various IBT systems Institution Acc 1st pt pt # 12/2010 PTC-H SCS May UFPTI icycl Aug comparable patient numbers with different approaches
33 Which accelerator to choose? Health services have to be economical: accelerator design unconstrained by financial and/or space limitations is not instrumental Balance size of accelerator with special features, e.g., single room vs. tomography option Balance facility cost with patient population, patient share, e.g., max. range vs. 3rd or 4th level care unit
34 efficiency and sustainability reducing weight reducing power consumption reducing neutron activation extending running time and service life saving raw materials/resources give numbers on sustainability!
35 the ideal medical accelerator Marco Pullia
36 the Blue Book U. Linz (ed) Ion Beam Therapy Ion Beam Therapy Fundamentals - Technology - Applications Series: Biological & Medical Physics Expected publication date: 10/2011
37 I Ion Beam Therapy in Perspective 1 From X-Rays to Ion Beams - A Short History of Radiation Therapy James M. Slater 2 The Place of Ion Beams in Clinical Applications Paul J. Kim, Helen A. Shih 3 Socio-Economic Aspects of Ion Beam II Therapy Andre Konski Physical and Biological Aspects 4 Physical and Biological Rationale for Using Ions in Therapy 5 Early and Late Responses to Ion Irradiation Reinhard Schulte, Ted Ling 6 The Impact of Radiation Quality on Cure III Rate John Gueulette, Reinhard Gahbauer, Dan Jones, Jacobus Slabbert, Andrˇ Wambersie Models and Preclinical Studies 7 Monte Carlo Methods for Dose Summary Talk of the Workshop the Blue Book: content I Calculations Katia Parodi 8 Modeling Heavy Ion Radiation Effects Thilo Elssser 9 Preclinical Radiobiology and Predictive Assays Eleanor A. Blakely, Polly Y. Chang IV Clinical Results and Indications 10 Treatment of Ocular Lesions Andrzej Kacperek 11 Clinical Indications for Carbon Ion Radiotherapy and Radiation Therapy with Other Heavier Ions Stephanie E. Combs 12 Skull Base Tumors Daniela Schulz-Ertner 13 Proton Therapy for Thoracoabdominal Tumors Hideyuki Sakurai, Toshiyuki Okumura, Shinji Sugahara, Hidetsugu Nakayama, Koichi Tokuuye 14 Carbon Ion Radiotherapy for Peripheral Stage I Non-Small Cell Lung Cancer Tadashi Kamada, Naoyoshi Yamamoto, Masayuki Baba 15 Ion Beam Therapy for Gynecological Tumors Tatsuya Ohno, Shingo Kato 16 Is Prostate Cancer a Good Candidate for Ion Beam Therapy? Carl J. Rossi, Jr. 17 Rationale for Proton Therapy in Pediatric Malignancies Shiao Y. Woo 18 Tolerance of Normal Tissues to Ion Beam Therapy Jean-Louis Habrand, Jean Datchary, Pascal Pommier, Stˇph anie Bolle, Lo c Feuvret, Ismael Ghorbel, Remi Dendale 19 Design and Implementation of Clinical V Trials of Ion Beam Therapy James D. Cox Medical Accelerators and Beam Line Design 20 Design Criteria for Medical Accelerators Hartmut Eickhoff, Udo Weinrich, Jose Alonso
38 the Blue Book: content II 21 Shielding and Radioprotection in Ion Beam Therapy Facilities Andrew J. Wroe, Steven Rightnar 22 Commercial Ion Beam Therapy Systems Yves Jongen 23 Advantages and Challenges of Superconducting Accelerators Detlef Krischel VI Beam Preparation and Control 24 All-in-One: An Atempt to Integrate the Full Potential of Proton Pencil Beam Scanning in a New Gantry System Eros Pedroni 25 Beam Spreading Devices Jay Flanz 26 Dosimetry Techniques for Ion Beams Giacomo Cuttone 27 Control and Safety Systems for Ion Beam Therapy Systems Hiroshi Akiyama, Kazuo Tomida 28 Considerations for Effective Quality Assurance Program for Proton Therapy Michael Gillin VII Patient Positioning and Treatment Planning 29 Imaging and Tumor Localization Oliver Jkel 30 Treatment Planning for Ion Beam Therapy Oliver Jkel 31 Online Irradiation Control by Means of PET Fine Fiedler, Daniela Kunath, Marlen Priegnitz, Wolfgang Enghardt 32 Compensation of Target Motion Christoph Bert, Eike Rietzel 33 Industrial Robots for Patient Support Andres Sommer VIIIŹIndividual Facilities and Management Issues 34 Twenty Years of Proton Radiation Therapy Center Jerry D. Slater at Loma Linda University Medical 35 The Francis H. Burr Proton Therapy Center Jay Flanz, Hanne Kooy, Thomas F. DeLaney 36 HIMAC - A New Start for Heavy Ions Tadashi Kamada, Hirohiko Tsujii 37 A National Action Plan in Japan - From Experimental Studies to Highly Advanced Medical Technology Koji Noda 38 Operational and Training Issues Related to Facility Start-Up Nancy P. Mendenhall, Zuofeng Li IX Future Developments 39 The Single-Room Ion Beam Facility Kenneth P. Gall 40 Smaller - Lighter - Cheaper: New Technological Concepts in Proton Therapy John Cameron, Niek Schreuder 41 New Facilities - Plans and Proposals Ramona Mayer, Stanislav Vatnitsky 42 Future Directions in Ion Beam Therapy Daniel Habermehl, Stephanie Combs, Jrgen Debus
Heavy Ion Tumor Therapy
Heavy Ion Tumor Therapy Applications Bence Mitlasoczki 25.06.2018 Heidelberg 1. Source (H 2 /CO 2 ) 2. Linac 3. Synchrotron 4. Guide 5. Treatment rooms 6. X-ray system 7. Gantry 8. Treatment room with
More informationA review of cyclotrons for Hadron Therapy. Y. Jongen Cyclotrons 2010 Lanzhou, September
A review of cyclotrons for Hadron Therapy Y. Jongen Cyclotrons 2010 Lanzhou, September 10 2010 The early days The possible use of the Bragg peak of high energy ions in the radiotherapy of cancer was suggested
More informationSUMITOMO Particle Therapy Technologies
55 th AAPM annual meeting Particle Beam Therapy Symposium SUMITOMO Particle Therapy Technologies August 3, 2013 Yukio Kumata Experience accelerators for science Current Status proton and carbon Future
More informationReview of Heavy Ion Accelerators for Hadrontherapy
Review of Heavy Ion Accelerators for Hadrontherapy Koji Noda Research Center for Charged Particle Therapy National Institute of Radiological Sciences 11 th Int l Conf. on Heavy Ion Accelerator Technology,
More informationPAMELA Particle Accelerator for MEdicaL Applications
PAMELA Particle Accelerator for MEdicaL Applications Suzie Sheehy, DPhil candidate John Adams Institute for Accelerator Science Particle Physics, University of Oxford 1 Clinical Requirements Charged Particle
More informationReview of Hadron machines for cancer therapy
Review of Hadron machines for cancer therapy M. Kanazawa NIRS cancer therapy with hadron (p, C) Clinical studies at New ideas of accelerators Compact facilities (p, C) Depth dose distribution Carbon, proton
More informationNew Treatment Research Facility Project at HIMAC
New Treatment Research Facility Project at Koji Noda Research Center for Charged Particle Therapy National Institute of Radiological Sciences IPAC10, Kyoto, JAPAN, 25th May, 2010 Contents 1. Introduction
More informationAspects of Industrialization of Accelerators for Particle Therapy ICABU, November 11, 2013, Daejeon
Aspects of Industrialization of Accelerators for Particle Therapy ICABU, November 11, 2013, Daejeon Introduction Why Particle Therapy? PT Milestones What is meant by Industrialization Examples Protons-only:
More informationPresent Status and Future Developments in Proton Therapy
Present Status and Future Developments in Proton Therapy Alfred R. Smith Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030,
More informationH. Röcken, M. Abdel-Bary, E. Akcöltekin, P. Budz, T. Stephani, J. Wittschen
: Medical Operation of the 2 nd Machine, Production and Commissioning Status of Machines No. 3 to 7 H. Röcken, M. Abdel-Bary, E. Akcöltekin, P. Budz, T. Stephani, J. Wittschen VARIAN Medical Systems Particle
More informationThe Heidelberg Ion Therapy Center and PARTNER. Thomas Haberer Heidelberg Ion Therapy Center
The Heidelberg Ion Therapy Center and PARTNER Thomas Haberer Heidelberg Ion Therapy Center Goal The key element to improve the clinical outcome is local control! entrance channel: low physical dose low
More informationCharacterization and implementation of Pencil Beam Scanning proton therapy techniques: from spot scanning to continuous scanning
Characterization and implementation of Pencil Beam Scanning proton therapy techniques: from spot scanning to continuous scanning Supervisors Prof. V. Patera PhD R. Van Roermund Candidate Annalisa Patriarca
More informationSCIENTIFIC AND TECHNOLOGICAL DEVELOPMENT OF HADRONTHERAPY
SCIENTIFIC AND TECHNOLOGICAL DEVELOPMENT OF HADRONTHERAPY SAVERIO BRACCINI * Albert Einstein Centre for Fundamental Physics, Laboratory for High Energy Physics (LHEP), University of Bern, Sidlerstrasse
More informationStatus of Hadrontherapy facilities worldwide
Status of Hadrontherapy facilities worldwide Vienna 15.03.2011 The Gantry 1 of PSI Eros Pedroni Center for Proton Radiation Therapy Paul Scherrer Institute SWITZERLAND Author s competence: Gantry with
More informationREVIEW ON CYCLOTRONS FOR CANCER THERAPY
FRM1CIO01 Proceedings of CYCLOTRONS 2010, Lanzhou, China REVIEW ON CYCLOTRONS FOR CANCER THERAPY Yves Jongen#, IBA, Louvain-la-Neuve, Belgium Abstract The science and technology of proton and carbon therapy
More informationPROGRESS IN HADRONTHERAPY
PROGRESS IN HADRONTHERAPY Saverio Braccini TERA Foundation for Oncological Hadrontherapy IPRD06 - Siena - 01.10.06 - SB 1 Outline Introduction Radiation therapy with X rays and hadrontherapy Hadrontherapy
More informationThe Heidelberg Ion Therapy Center. Thomas Haberer Heidelberg Ion Therapy Center Hadron Therapy Workshop, Erice 2009
The Heidelberg Ion Therapy Center Thomas Haberer Heidelberg Ion Therapy Center Hadron Therapy Workshop, Erice 2009 Goal The key element to improve the clinical outcome is local l control! entrance channel:
More informationThe Advantages of Particle Therapy and the Status of the Heidelberg Iontherapy Center
The Advantages of Particle Therapy and the Status of the Heidelberg Iontherapy Center Thomas Haberer, Scientific Technical Director, Heidelberg Ion Therapy Center Situation / Indications 2/3 patients suffer
More informationRoad Map for the development of hadron therapy and associated nuclear medicine methods at JINR:
НТС ОЭЗ, 07 октября 2011 Road Map for the development of hadron therapy and associated nuclear medicine methods at JINR: Development of 3D conformal Proton therapy Design of various devices for proton
More informationSummary of Synchrotron for Hadron Therapy
Summary of Synchrotron for Hadron Therapy April 30, 09 Koji Noda 1. G.H. Rees ; A New Tracking Gantry-Synchrotron Idea 2. K. Noda ; Overview of NIRS Accelerator Activity 3. T. Haberer ; The Heidelberg
More informationWorkshop on Hadron Beam Therapy of Cancer Erice, Sicily April 24-May
IONTRIS Synchrotron based PT Solutions from Siemens AG Workshop on Hadron Beam Therapy of Cancer Erice, Sicily April 24-May 1 2009 Matthias Herforth VP Business Development and Communications Siemens AG
More informationTreatment Planning (Protons vs. Photons)
Treatment Planning Treatment Planning (Protons vs. Photons) Acquisition of imaging data Delineation of regions of interest Selection of beam directions Dose calculation Optimization of the plan Hounsfield
More informationIntroduction to Ion Beam Cancer Therapy
Introduction to Ion Beam Cancer Therapy Andrew M. Sessler (with some slides from David Robin) Lawrence Berkeley National Laboratory Berkeley, CA 94720 Cyclotron 10, Lanzhou September 10, 2010 Contents
More informationIII. Proton-therapytherapy. Rome SB - 5/5 1
Outline Introduction: an historical review I Applications in medical diagnostics Particle accelerators for medicine Applications in conventional radiation therapy II III IV Hadrontherapy, the frontier
More informationT.Kanai, K. Yusa, M. Tashiro, H. Shimada, K. Torikai, Gunma University, Gunma, Japan
The carbon-ion cancer therapy facility at Gunma University T.Kanai, K. Yusa, M. Tashiro, H. Shimada, K. Torikai, J. Koya, T. Ishii, Y. Yoshida, S. Yamada, T. Ohno, T. Nakano Gunma University, Gunma, Japan
More informationProf. Dr. Thomas Haberer Scientific-technical Director Heidelberg Iontherapy Center
The Heidelberg Ion Beam Therapy Center A Hospital-based Facility Dedicated to Precision and Flexibility Prof. Dr. Thomas Haberer Scientific-technical Director Heidelberg Iontherapy Center Carbon Ion Therapy
More informationWELCOME. is also available. OncoRay National Center for Radiation Research in Oncology, Dresden
OncoRay National Center for Radiation Research in Oncology, Dresden WELCOME Wifi: Network: UKD_Dozent Username: ukd-guest536 Password: mvhffjs3 is also available OncoRay National Center for Radiation Research
More informationABSTRACTS. of the NIRS International Seminar on the Heavy Charged Particle Therapy for Cancer and the XXVII PTCOG MEETING.
P ROTON THERAPY C O- OPERATIVE GROUP Chair Michael Goitein Ph. D. Department of Radiation Oncology Massachusetts General Hospital Boston MA 02114 (617) 724-9529 (617) 724-9532 Fax Secret ary Janet Sisterson
More informationAn Introduction to Cancer Therapy With Hadron Radiation
An Introduction to Cancer Therapy With Hadron Radiation Andrew M. Sessler Lawrence Berkeley National Laboratory Berkeley, CA 94720 April, 2008 Contents 1. History 2. X-Ray Machines 3. Why Hadrons? Which
More informationPresent status and future of Proton beam therapy
Present status and future of Proton beam therapy Description At present, the types of proven treatment for cancer are surgery, radiotherapy, and chemotherapy. Depending on the characteristics of cancer
More informationProton Treatment. Keith Brown, Ph.D., CHP. Associate Director, Radiation Safety University of Pennsylvania
Proton Treatment Keith Brown, Ph.D., CHP Associate Director, Radiation Safety University of Pennsylvania Proton Dose vs. Depth Wilson,. R.R. Radiological use of fast protons. Radiology 47:487-491, 1946.
More informationHIMAC AND MEDICAL ACCELERATOR PROJECTS IN JAPAN
HIMAC AND MEDICAL ACCELERATOR PROJECTS IN JAPAN S. Yamada, T. Honma, M. Kanazawa, A. Kitagawa, S. Kouda, M. Kumada, T. Murakami, M. Muramatsu, T. Nishio, K. Noda, Y. Sato, M. Suda and E. Takada, Research
More informationProgress of Heavy Ion Therapy
Progress of Heavy Ion Therapy Fuminori Soga Division of Accelerator Physics and Engineering, National Institute of Radiological Sciences, 4-9-1 Anagawa. Inage-ku, Chiba 263-8555, Japan 1. Introduction
More informationACCELERATORS FOR HADRONTHERAPY
ACCELERATORS FOR HADRONTHERAPY Alberto Degiovanni CERN-BE IVICFA s Fridays: Medical Physics Valencia, 31.10.2014 Introduction: the icon of hadrontherapy Position of the Bragg peak depends on beam energy
More informationRadiation qualities in carbon-ion radiotherapy at NIRS/HIMAC
Radiation qualities in carbon-ion radiotherapy at NIRS/ Shunsuke YONAI Radiological Protection Section Research Center for Charged Particle Therapy National Institute of Radiological Sciences (NIRS) E-mail:
More informationPlans for the Precision Cancer Medicine Institute University of Oxford
Plans for the Precision Cancer Medicine Institute University of Oxford STFC & Particle Accelerators and Beams group workshop on particle accelerators for medicine 17 th February 2015 Claire Timlin The
More informationLearning Objectives. Clinically operating proton therapy facilities. Overview of Quality Assurance in Proton Therapy. Omar Zeidan
Overview of Quality Assurance in Proton Therapy Omar Zeidan AAPM 2012 Charlotte, NC July 30 st, 2012 Learning Objectives Understand proton beam dosimetry characteristics and compare them to photon beams
More informationClinical Results of Carbon Ion Radiotherapy: The Heidelberg Experience
Clinical Results of Carbon Ion Radiotherapy: The Heidelberg Experience Stephanie E. Combs, MD Department of Radiation Oncology University of Heidelberg, Germany Carbon ion RT at GSI Active beam delivery
More information*Chien-Yi Yeh, Ji-Hong Hong * 葉健一洪志宏
林口 Proton Therapy in Ti Taiwan *Chien-Yi Yeh, Ji-Hong Hong * 葉健一洪志宏 Chang Gung Memorial Hospital at Lin-Kou, Taiwan 林口長庚紀念醫院 OCPA2010 at Beijing, China Aug. 5, 2010 Outline 1. The principle of proton radiotherapy
More informationCancer: A Medical Challenge for Physics
Cancer: A Medical Challenge for Physics Ken Peach Particle Therapy Cancer Research Institute (Oxford Martin School) & John Adams Institute for Accelerator Science, University of Oxford Lund, April 9 th
More informationCancer Treatment by Charged Particles - Carbon Ion Radiotherapy -
Cancer Treatment by Charged Particles - Carbon Ion Radiotherapy - Takeshi Murakami Research Center of Charged Particle Therapy National Institute of Radiological Sciences 2012.11.21 1. Introduction to
More informationIon Beam Therapy should we prioritise research on helium beams?
Ion Beam Therapy should we prioritise research on helium beams? Stuart Green Medical Physics University Hospital Birmingham NHS Trust Follow-up from the EUCARD2 workshop, ION Beam Therapy: Clinical, Scientific
More informationNUCLEAR PHYSICS FOR MEDICINE - HADRON THERAPY. Pawel Olko Institute of Nuclear Physics Krakow Poland
NUCLEAR PHYSICS FOR MEDICINE - HADRON THERAPY Pawel Olko Institute of Nuclear Physics Krakow Poland The NuPECC report: Nuclear Physics in Medicine http://www.nupecc.org/pub/npmed2014.pdf Outline 1. Why
More informationFuture Proton Irradiation Facility at OncoRay
Future Proton Irradiation Facility at OncoRay Seminar am Institut für Kern- und Teilchenphysik Technische Universität Dresden 14. Juli 2011 Wolfgang Enghardt OncoRay National Center for Radiation Research
More informationStatus of H 1 and C 12
Status of H 1 and C 12 Herman Suit No Conflict of Interest 1 Goal of a New Treatment Modality Tumor Control Probability or No in Complication Rate 2 Truism No Advantage to: any Patient for any Radiation
More informationApplications of Particle Accelerators
Applications of Particle Accelerators Prof. Rob Edgecock STFC Rutherford Appleton Laboratory EMMA Accelerator at Daresbury Laboratory Applications >30000 accelerators in use world-wide: 44% for radiotherapy
More informationProton Beam Therapy at Mayo Clinic
Proton Beam Therapy at Mayo Clinic Jon J. Kruse, Ph.D. Mayo Clinic Dept. of Radiation Oncology Rochester, MN History of Proton Therapy at Mayo 2002: Decided to consider particle therapy analysis and education
More informationState-of-the-art proton therapy: The physicist s perspective
State-of-the-art proton therapy: Tony Lomax, Centre for Proton Radiotherapy, Paul Scherrer Institute, Switzerland Overview of presentation 1. State-of-the-art proton delivery 2. Current challenges 3. New
More informationThe Heidelberg Ion Therapy (HIT) Accelerator Coming Into Operation. Presented at EPAC 2008, Genova D. Ondreka, GSI
The Heidelberg Ion Therapy (HIT) Accelerator Coming Into Operation Presented at EPAC 2008, Genova D. Ondreka, GSI Introduction Heidelberg Ion Therapy Centre: Europe's first dedicated particle therapy facility
More informationNuclear Physics in Proton Radiotherapy
Nuclear Physics in Proton Radiotherapy Cynthia Keppel, PhD Thomas Jefferson National Accelerator Facility (Hampton University Proton Therapy institute) International Nuclear Physics Conference Adelaide,
More informationProton and heavy ion radiotherapy: Effect of LET
Proton and heavy ion radiotherapy: Effect of LET As a low LET particle traverses a DNA molecule, ionizations are far apart and double strand breaks are rare With high LET particles, ionizations are closer
More informationModern Hadron Therapy Gantry Developments. 16th Jan 2014
Modern Hadron Therapy Gantry Developments 16th Jan 2014 Protect, Enhance, and Save Lives - 2 - IBA ProteusONE THE TREND: MORE COMPACT, CHEAPER Access to PT is key ProteusPLUS ProteusONE 18000 ft² / 1672
More informationHEALTH RISKS FROM EXPOSURE TO FAST NEUTRONS. Prof. Marco Durante
HEALTH RISKS FROM EXPOSURE TO FAST NEUTRONS Prof. Marco Durante Risk from neutrons Risk from exposure to fission spectrum neutrons has been extensively studied in the 60 s at nuclear reactors using animal
More informationRadiotherapy. Marta Anguiano Millán. Departamento de Física Atómica, Molecular y Nuclear Facultad de Ciencias. Universidad de Granada
Departamento de Física Atómica, Molecular y Nuclear Facultad de Ciencias. Universidad de Granada Overview Introduction Overview Introduction Brachytherapy Radioisotopes in contact with the tumor Overview
More informationCyclotrons - Outline. summary development routes, Pro s and Con s of cyclotrons
1 Cyclotrons - Outline cyclotron concepts history of the cyclotron, basic concepts and scalings, focusing, classification of cyclotron-like accelerators medical cyclotrons requirements for medical applications,
More informationPractical Challenges and Opportunities for Proton Beam Therapy. M. F. Moyers Loma Linda University Medical Center
Practical Challenges and Opportunities for Proton Beam Therapy M. F. Moyers Loma Linda University Medical Center Outline I. Introduction II. Registration and Immobilization III. Beam Shaping IV. Localization
More informationAccelerator Seminar, April 2013
, H. Röcken VARIAN Medical Systems Particle Therapy GmbH Friedrich-Ebert-Str. 1 D-51429 BERGISCH GLADBACH GERMANY OUTLINE Why having a Superconducting Cyclotron? Some Basics VARIAN PT Cyclotrons: ProBeam
More informationHEAVY PARTICLE THERAPY
HEAVY PARTICLE THERAPY DR. G.V. GIRI KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY ICRO 2012 BHATINDA HEAVY PARTICLES USED IN A EFFORT TO IMPROVE TUMOR CONTROL, THAT DO NOT RESPOND TO PHOTONS OR ELECTRONS BETTER
More informationMEDICAL PHYSICS ASPECTS OF PARTICLE THERAPY Oliver Jäkel 1,2, *
Radiation Protection Dosimetry (2009), Vol. 137, No. 1 2, pp. 156 166 Advance Access publication 14 October 2009 doi:10.1093/rpd/ncp192 MEDICAL PHYSICS ASPECTS OF PARTICLE THERAPY Oliver Jäkel 1,2, * 1
More informationDevelopment of LINAC-Based Neutron Source for Boron Neutron Capture Therapy in University of Tsukuba )
Development of LINAC-Based Neutron Source for Boron Neutron Capture Therapy in University of Tsukuba ) Hiroaki KUMADA, Fujio NAITO 1), Kazuo HASEGAWA 2), Hitoshi KOBAYASHI 1), Toshikazu KURIHARA 1), Kenta
More informationStatus of Proton Therapy: results and future trends
Status of Proton Therapy: results and future trends E. Pedroni Paul Scherrer Institute Division of Radiation Medicine CH-5232 Villigen PSI Abstract The number of centres investigating proton therapy in
More informationPlanning for the Installation of a Compact Superconducting Proton Therapy Unit in a Busy Medical Center Environment
Planning for the Installation of a Compact Superconducting Proton Therapy Unit in a Busy Medical Center Environment Barry W. Wessels, Ph.D. Director of Medical Physics and Dosimetry Case Western Reserve
More informationIN VIVO IMAGING Proton Beam Range Verification With PET/CT
IN VIVO IMAGING Proton Beam Range Verification With PET/CT Antje-Christin Knopf 1/3 K Parodi 2, H Paganetti 1, T Bortfeld 1 Siemens Medical Solutions Supports This Project 1 Department of Radiation Oncology,
More informationProton Therapy Dosimetry & Clinical Implementation. Baldev Patyal, Ph.D., Chief Medical Physicist Department of Radiation Medicine
Proton Therapy Dosimetry & Clinical Implementation Baldev Patyal, Ph.D., Chief Medical Physicist Department of Radiation Medicine Outline» Proton Therapy Basics» Why Proton Therapy? (Dosimetric Superiority)»
More informationBasic Press Information
Basic Press Information Contact MedAustron EBG MedAustron GmbH Marie Curie-Strasse 5 A-2700 Wiener Neustadt Austria T +43 2622 26 100-0 e-mail: office@medaustron.at Internet: www.medaustron.at Press contact:
More informationA brief presentation of The TERA Foundation
A brief presentation of The TERA Foundation David Watts on behalf of Prof. Ugo Amaldi and all my colleagues at TERA TERA Overview Direction: Prof. Ugo Amaldi AQUA (Advanced QUAlity Assurance) Cyclinac
More informationMedical Applications with Laser Plasma Accelerators
Medical Applications with Laser Plasma Accelerators Victor Malka Laboratoire d Optique Appliquée ENSTA ParisTech Ecole Polytechnique ParisTech CNRS PALAISEAU, France victor.malka@ensta.fr Thanks to : J.
More informationLook! Borg get upgrade already!
Cancer, Partikel Terapi and PT accelerators Look! Borg get upgrade already! 1 Cancer, Partikel Terapi and PT accelerators Basic requirements to PT accelerator Accelerators for PT Siemens PT maskinen Alternativer:
More informationPHYS 383: Applications of physics in medicine (offered at the University of Waterloo from Jan 2015)
PHYS 383: Applications of physics in medicine (offered at the University of Waterloo from Jan 2015) Course Description: This course is an introduction to physics in medicine and is intended to introduce
More informationUpgrade plan of cerl for the POC as a first stage of the development on EUV-FEL high power light source
Upgrade plan of cerl for the POC as a first stage of the development on EUV-FEL high power light source Hiroshi Kawata, Norio Nakamura, and Ryukou Kato, High Energy Accelerator Research Organization (KEK),
More informationJefferies Healthcare Conference
Jefferies Healthcare Conference Jean-Marc BOTHY - CSO June 8, 2017 2017 IBA SA Disclaimer This presentation may contain forward-looking statements concerning industry outlook, including growth drivers;
More informationYour co-operation partner for research. EUROPEAN UNION European Regional Development Fund
Med Austron Research Your co-operation partner for research EUROPEAN UNION European Regional Development Fund MedAustron MedAustron offers protons and carbon ions for therapy and research. With MedAustron,
More informationCYCLOTRON PERFORMANCE AND NEW DEVELOPMENTS
CYCLOTRON PERFORMANCE AND NEW DEVELOPMENTS Th.Stammbach, S.Adam, A.Mezger, P.A.Schmelzbach, P.Sigg PSI CH-5232 Villigen PSI, Switzerland Abstract New developments in the design and use of cyclotrons are
More informationRecent advances in dosimetry in reference conditions for proton and light-ion beams
Recent advances in dosimetry in reference conditions for proton and light-ion beams S. Vatnitskiy a), P. Andreo b) and D.T.L. Jones c) a) MedAustron, Wiener Neustadt, Austria b) Medical Radiation Physics,
More information8/1/2016. Motion Management for Proton Lung SBRT. Outline. Protons and motion. Protons and Motion. Proton lung SBRT Future directions
Motion Management for Proton Lung SBRT AAPM 2016 Outline Protons and Motion Dosimetric effects Remedies and mitigation techniques Proton lung SBRT Future directions Protons and motion Dosimetric perturbation
More informationBiological Optimization of Hadrontherapy. Uwe Oelfke
4/2/2012 page 1 Biological Optimization of Hadrontherapy Uwe Oelfke DKFZ Heidelberg (E040) Im Neuenheimer Feld 280 69120 Heidelberg, Germany u.oelfke@dkfz.de 4/2/2012 page 2 Contents Introduction and General
More informationProton and helium beams: the present and the future of light ion beam therapy
Proton and helium beams: the present and the future of light ion beam therapy Dr. Andrea Mairani Group Leader Biophysics in Particle Therapy Heidelberg Ion Beam Therapy Center HIT Department of Radiation
More informationMaintenance and Logistics Experience at Loma Linda Proton Treatment Facility
Maintenance and Logistics Experience at Loma Linda Proton Treatment Facility Baldev Patyal, Ph.D., Chief Medical Physicist Department of Radiation Medicine Outline Loma Linda Proton Treatment Facility
More informationPTCOG 46. Educational Workshop Session IV. Head & Neck CLINICAL. J. Mizoe (NIRS, Japan)
PTCOG 46 Educational Workshop Session IV CLINICAL Head & Neck J. Mizoe (NIRS, Japan) Photon X-Ray γ-ray Fast Neutron Non-Charged Radiation Electron Proton Helium Light Ion Heavy Particle Carbon Neon Argon
More informationThe first year of operation of PSI s new SC cyclotron and beam lines for proton therapy.
The first year of operation of PSI s new SC cyclotron and beam lines for proton therapy. Marco Schippers, Jürgen Duppich, Gudrun Goitein, Eugen Hug, Martin Jermann, Anton Mezger,Eros Pedroni, for the PROSCAN
More informationTreatment Efficiency and Optimization of Patient Care with IBA ProteusOne
Treatment Efficiency and Optimization of Patient Care with IBA ProteusOne Terry Wu, Ph.D. Chief Physicist, Radiation Oncology Department Willis-Knighton Cancer Center/Proton Therapy Center Shreveport,
More informationParticle Therapy- Why?
Particle Therapy- Why? Kill tumour without affecting healthy cells X-Ray Therapy Head, neck, Spinal cord Eyes, orbits Pelvis Prostate Lung PEDIATRIC Proton Therapy Photon IMRT Photon Proton (Courtesy of
More informationMitsubishi Heavy Industries Technical Review Vol. 51 No. 1 (March 2014)
The Challenge of Innovative Cancer Treatments Enabled by Vero4DRT -Development of High-precision Dose Delivery Features for Reducing Radiation Exposure of Healthy Tissue- 76 YASUNOBU SUZUKI *1 KUNIO TAKAHASHI
More informationParticle Therapy in the 21st Century: Relevance to Developing Countries
Applied Radiation Biology and Radiotherapy Section International Atomic Energy Agency Particle Therapy in the 21st Century: Relevance to Developing Countries Vienna International Centre Vienna, Austria
More informationMedical physics is beautiful
Translational research in particle therapy Marco Durante Medical physics is beautiful Pisa, 31.10.2014 Relative dose 1. 2 1. 0 Tumor Durante & Loeffler, Nature Rev Clin Oncol 2010 0. 8 Normal tissue 0.
More informationParticle Radiation Therapy: CurrentStatus Indications -Results
Particle Radiation Therapy: CurrentStatus Indications -Results Eugen B. Hug Center for Proton Therapy Paul Scherrer Institute and University of Zürich Switzerland Particle Radiation Therapy: Selection
More informationTHE HIGH-CURRENT DEUTERON ACCELERATOR FOR THE NEUTRON THERAPY. S.V. Akulinichev, A. V. Andreev, V.M. Skorkin
THE HIGH-CURRENT DEUTERON ACCELERATOR FOR THE NEUTRON THERAPY S.V. Akulinichev, A. V. Andreev, V.M. Skorkin Institute for Nuclear Research of the RAS, Russia THE PROJECT OF NEUTRON SOURCES FOR THE NEUTRON
More informationV. 4. Design and Benchmark Experiment for Cyclotron-based Neutron Source for BNCT
CYRIC Annual Report 2002 V. 4. Design and Benchmark Experiment for Cyclotron-based Neutron Source for BNCT Yonai S., ItogaT., Nakamura T., Baba M., Yashima, H. Yokobori H. *, and Tahara Y. ** Cyclotron
More informationTIMETABLE. Monday, 10 June, 2019 EDUCATIONAL SESSIONS. Exchange Room 9 Exchange Room 10 Exchange Room 11. Exchange Room 4+5.
Educational Sessions TIMETABLE Opening / Closing Ceremony Educational Sessions Physics Sessions RTT Sessions (Education) Clinical Sessions Faculty RTT Sessions (Scientific) New Investigator Session Keynote
More informationRadiotherapy for liver cancer
Received: 7 November 2015 Accepted: 10 March 2016 DOI: 10.1002/jgf2.19 REVIEW ARTICLE Radiotherapy for liver cancer Nobuyoshi Fukumitsu MD Toshiyuki Okumura MD Hideyuki Sakurai MD Proton Medical Research
More informationActivities at the Heidelberg Ion Therapy Center (HIT)
Activities at the Heidelberg Ion Therapy Center (HIT) The people A. Mairani (now INFN), F. Sommerer (Uniklinikum Heidelberg), I. Rinaldi (DKFZ Heidelberg), K. Parodi (HIT and University of Heidelberg)
More informationImage based in-vivo dosimetry: from PET to in-beam SPECT
Image based in-vivo dosimetry: from PET to in-beam SPECT 2nd Workshop on Hadron Beam Therapy of Cancer Erice, Sicily, Italy May 25th, 2011 Fine Fiedler Institute of Radiation Physics Text optional: Institutsname
More informationUK FEL R&D Plans Jim Clarke
UK FEL R&D Plans Jim Clarke STFC Daresbury Laboratory & The Cockcroft Institute IoP PAB/STFC Workshop Towards a UK XFEL 16 th February 2016 Contents UK Context & Selected FEL projects 4GLS ALICE NLS SwissFEL
More informationApplication of the Multi-Model Monte-Carlo Treatment Planning System Combined with PHITS to Proton Radiotherapy
1 1 6 2 1 2 3 5 6 7 9 1 1 1 1 2 1 3 1 1 5 1 6 1 7 1 1 9 2 2 1 Progress in NUCLEAR SCIENCE and TECHNOLOGY, Vol. 2, pp.213-21 (211) DOI: 1.15669/pnst.2.213 ARTICLE Application of the Multi-Model Monte-Carlo
More informationToday, I will present the second of the two lectures on neutron interactions.
Today, I will present the second of the two lectures on neutron interactions. 1 The main goal of this lecture is to tell you a little about clinical neutron therapy, first with fast neutron beams, and
More informationUnited States Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022
United States Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022 United States Proton Therapy Market (Actual & Potential), Patients Treated,
More informationResearch on Cancer Therapy with Carbon Beams Development of Human Friendly Cancer Therapy with Carbon Ion Beams
Research on Cancer Therapy with Carbon Beams Development of Human Friendly Cancer Therapy with Carbon Ion Beams Tadashi Kamada, M.D., Ph.D. Director of Research Center for Charged Particle Therapy E-mail:
More informationTumor Therapy with Heavy Ions at GSI Darmstadt
Tumor Therapy with Heavy Ions at GSI Darmstadt D. Schardt 1) for the Heavy Ion Therapy Collaboration 2) 1) Gesellschaft für Schwerionenforschung (GSI), Darmstadt, Germany 2) GSI Darmstadt / Radiologische
More informationParticle Therapy Systems by Mitsubishi Electric DG1101-KM-0034
Particle Therapy Systems by Mitsubishi Electric DG1101-KM-0034 Saudi-Japan Business Opportunities Forum February 1 2, 2012 1 2 Types of Treatment Conventional Radiation Therapy Uses photons (energetic
More informationBeam Loss and Collimation in the ESS Linac
Beam Loss and Collimation in the ESS Linac Ryoichi Miyamoto (ESS) B. Cheymol, H. Danared, M. Eshraqi, A. Ponton, J. Stovall, L. Tchelidze (ESS) I. Bustinduy (ESS-Bilbao) H. D. Thomsen, A. I. S. Holm, S.
More information